Vital KSK HoldingsTSE:3151 -0.85%68 ROA % is 1.77% as of Mar. 2026, which is 14% above its 10-year median of 1.55. GuruFocus rates TSE:3151 with a GF Score™ of 68/100 and a GF Value™ of 円1,322.65 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 120 Medical Distribution companies, Vital KSK Holdings ranks better than 53.33% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Vital KSK Holdings's annualizedNet Income for the quarter that ended in Mar. 2026 was 円5,892 Mil.
Vital KSK Holdings's average Total Assets over the quarter that ended in Mar. 2026 was 円332,485 Mil. Therefore, Vital KSK Holdings's annualized ROA % for the quarter that ended in Mar. 2026 was 1.77%.
The historical rank and industry rank for Vital KSK Holdings's ROA % or its related term are showing as below:
TSE:3151'
s ROA % Range Over the Past 10 Years
Min: 0.38 Med: 1.55 Max: 2.37
Current: 2.32
During the past 13 years, Vital KSK Holdings's highest ROA % was 2.37%. The lowest was 0.38%. And the median was 1.55%.
TSE:3151's ROA % is ranked better than 53.33% of 120
companies
in the Medical Distribution industry
Industry Median: 2.23
vs TSE:3151: 2.32
Vital KSK Holdings (TSE:3151) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Vital KSK Holdings ROA % Related Terms
Vital KSK Holdings ROA % Historical Data
* Premium members only.
The historical data trend for Vital KSK Holdings's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Vital KSK Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital KSK Holdings ROA % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's ROA % distribution charts can be found below:
* The bar in red indicates where Vital KSK Holdings's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Vital KSK Holdings (TSE:3151) has a ROA % of 1.77% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Vital KSK Holdings and its competitors. This is 14% above median its historical median of 1.55. Over the past decade, Vital KSK Holdings' ROA % has ranged from 0.38 to 2.37. According to the industry distribution chart, Vital KSK Holdings ranks #56 out of 120 companies in the Medical Distribution industry, placing it in the top 46.7%.
Is Vital KSK Holdings' ROA % too high?
Vital KSK Holdings' current ROA % of 1.77% is 14% above median its 10-year median of 1.55. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 2.37. The Medical Distribution industry median ROA % is 2.23. Vital KSK Holdings' value of 1.77% is 20.6% below this industry median. Based on the distribution chart, Vital KSK Holdings ranks #56 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Vital KSK Holdings has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' ROA % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Vital KSK Holdings ranks #56 out of 120 companies for ROA %. This puts Vital KSK Holdings in the upper half of its industry. The industry median ROA % is 2.23. Vital KSK Holdings' value of 1.77% is 20.6% below this benchmark. Historically, Vital KSK Holdings' own ROA % has ranged from 0.38 to 2.37 over the past decade. While the company's 10-year median is 1.55 vs. the industry median of 2.23, Vital KSK Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Distribution company?
The median ROA % among Medical Distribution companies is 2.23, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital KSK Holdings's current ROA % of 1.77% is 20.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Vital KSK Holdings and its competitors. For the Medical Distribution industry, the median ROA % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital KSK Holdings's current ROA % is 1.77%, which is 14% above median its own 10-year median of 1.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,322.65, compared to a current price of 円1,520.00 — trading 14.9% above its estimated fair value. The current ROA % is 1.77%, which is 14% above median its 10-year median of 1.55 and 20.6% below the Medical Distribution industry median of 2.23. Vital KSK Holdings' overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current ROA % is 1.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?
Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued.
The current stock price of 円1,520.00 is trading 14.9% above its estimated GF Value™ of 円1,322.65.
GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.
Key valuation signals for TSE:3151:
ROA %: 1.77% (14% above median its 10-year median of 1.55)
GF Value™: 円1,322.65 vs. price of 円1,520.00 (14.9% above fair value)
Industry Position: 20.6% below the Medical Distribution median (#56 of 120)
No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
68GF Score
Get the complete analysis for TSE:3151
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3151 has been successfully added to your 
